Skip to main content

Advertisement

SpringerLink
Log in

Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

We report the results of unrelated cord blood transplantation (UCBT) for patients with adult T-cell leukemia/lymphoma (ATLL) conducted in our single institute. Ten patients with ATLL (nine acute and one lymphoma-type) received UCBT during the period from August 2003 to July 2011. The median age at the time of diagnosis of ATLL was 51 years (range 37–64). The median period from diagnosis of ATLL to UCBT was 130 days (range 94–344). Conditioning regimens were myeloablative for six and reduced intensity for four. The median number of infused nucleated cells and CD34 positive cells were 2.52 × 107/kg and 1.04 × 105/kg, respectively. There was no engraftment failure. Three patients developed grade II acute graft versus host disease, and four developed grade III. The estimated 2-year overall survival was 40 % (95 % CI 12–67 %). Four of six chemosensitive patients prior to UCBT survived for 1035, 793, 712, and 531 days post-UCBT, respectively. There were no survivors among the four chemorefractory patients prior to UCBT. Our data indicates that UCBT is feasible and provides long-term survival in patients with chemosensitive ATLL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.

    PubMed  CAS  Google Scholar 

  2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79:2031–5.

    Article  PubMed  CAS  Google Scholar 

  3. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Nat Acad Sci USA. 1980;77:7415–9.

    Article  PubMed  CAS  Google Scholar 

  4. Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia–lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458–64.

    Article  PubMed  CAS  Google Scholar 

  5. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15–20.

    Article  PubMed  CAS  Google Scholar 

  6. Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia. 2005;19:829–34.

    Article  PubMed  CAS  Google Scholar 

  7. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood. 2005;105:4143–5.

    Article  PubMed  CAS  Google Scholar 

  8. Choi I, Tanosaki R, Uike N, et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant. 2011;46:116–8.

    Article  PubMed  CAS  Google Scholar 

  9. Shimoyama M. Members of The Lymphoma Study G. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia–lymphoma. Br J Haematol. 1991;79:428–37.

    Article  PubMed  CAS  Google Scholar 

  10. Katsuya H, Yamanaka T, Ishitsuka K, et al. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. J Clin Oncol. 2012.

  11. Tsukasaki K, Hermine O, Bazarbachi A, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia–lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27:453–9.

    Article  PubMed  Google Scholar 

  12. Taguchi H, Kinoshita KI, Takatsuki K, et al. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:182–6.

    Article  PubMed  CAS  Google Scholar 

  13. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001;113:375–82.

    Article  PubMed  CAS  Google Scholar 

  14. Uchida N, Wake A, Takagi S, et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant. 2008;14:583–90.

    Article  PubMed  Google Scholar 

  15. Takanashi M, Fujiwara K, Tanaka H, Satake M, Nakajima K. The impact of HLA antibodies on engraftment of unrelated cord blood transplants. Transfusion. 2008;48:791–3.

    Article  PubMed  Google Scholar 

  16. Hishizawa M, Kanda J, Utsunomiya A, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116:1369–76.

    Article  PubMed  CAS  Google Scholar 

  17. Atsuta Y, Suzuki R, Nagamura-Inoue T, et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood. 2009;113:1631–8.

    Article  PubMed  Google Scholar 

  18. Takanashi M, Atsuta Y, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116:2839–46.

    Article  PubMed  CAS  Google Scholar 

  19. Wake A, Kato D, Takagi S, et al. Reduced-intensity cord blood transplantation (RICBT) is a feasible approach for advanced adult T-cell leukemia (ATL). Blood (ASH Annual Meeting Abstracts). 2005;106:5448.

    Google Scholar 

  20. Narimatsu H, Murata M, Sugimoto K, Terakura S, Kinoshita T, Naoe T. Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2007;48:841–3.

    Article  PubMed  Google Scholar 

  21. Takizawa J, Aoki S, Kurasaki T, et al. Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation. Am J Hematol. 2007;82:1113–5.

    Article  PubMed  CAS  Google Scholar 

  22. Nomura S, Ishii K, Shimizu M, Inami N, Urase F, Maeda Y. Inflammatory pseudotumor following cord blood transplantation for adult T-cell leukemia. Bone Marrow Transplant. 2008;42:493–4.

    Article  PubMed  CAS  Google Scholar 

  23. Yonekura K, Utsunomiya A, Takatsuka Y, et al. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:1029–35.

    Article  PubMed  CAS  Google Scholar 

  24. Tanosaki R, Uike N, Utsunomiya A, et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant. 2008;14:702–8.

    Article  PubMed  CAS  Google Scholar 

  25. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60.

    Article  PubMed  Google Scholar 

  26. Atsuta Y, Morishima Y, Suzuki R, et al. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Biol Blood Marrow Transplant. 2012;18:780–7.

    Google Scholar 

  27. Kamimura T, Miyamoto T, Kawano N, et al. Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2012;95:725–30.

    Google Scholar 

  28. Miyagawa Y, Kiyokawa N, Ochiai N, et al. Ex vivo expanded cord blood CD4 T lymphocytes exhibit a distinct expression profile of cytokine-related genes from those of peripheral blood origin. Immunology. 2009;128:405–19.

    Article  PubMed  CAS  Google Scholar 

  29. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia–lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30:837–42.

    Article  PubMed  CAS  Google Scholar 

  30. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci. 2006;97:1139–46.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan

    Takayuki Nakamura, Eijiro Oku, Kei Nomura, Satoshi Morishige, Yuka Takata, Ritsuko Seki, Rie Imamura, Koichi Osaki, Michitoshi Hashiguchi, Kazuaki Yakushiji, Fumihiko Mouri, Shinichi Mizuno, Koji Yoshimoto, Koji Nagafuji & Takashi Okamura

  2. Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan

    Koichi Ohshima

Authors
  1. Takayuki Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eijiro Oku
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kei Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoshi Morishige
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuka Takata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ritsuko Seki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rie Imamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Koichi Osaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michitoshi Hashiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kazuaki Yakushiji
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Fumihiko Mouri
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shinichi Mizuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Koji Yoshimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Koichi Ohshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Koji Nagafuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Takashi Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koji Nagafuji.

About this article

Cite this article

Nakamura, T., Oku, E., Nomura, K. et al. Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute. Int J Hematol 96, 657–663 (2012). https://doi.org/10.1007/s12185-012-1177-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1177-8

Keywords

Search

Navigation